Bibliografia: Il mondo dentro di noi

Articolo L’altra Medicina N. 87 – 07/2019
Bibliografia

  1. Gasbarrini Antonio. Il Microbiota Intestinale – il 4 Organo dell’Apparato Digerente,composizione, funzioni e patologie correlate.2013 Verduci Editore
  1. Lozio Luciano -Microbiota intestinale – Preservare il corretto equilibrio dell’Intestino 2011. Tecniche Nuove.
  1. Drago L, Toscano M, Rodighiero V, De Vecchi E, Mogna G. Cultivable and pyrosequenced fecal microflora in centenarians and young subjects.J Clin Gastroenterol. 2012 Oct;46 Suppl: S81.
  1. Maynard CL1, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system.Nature. 2012 Sep 13;489(7415):231-
  1. Sanada T1, Kim M, Mimuro H, Ashida H, Ogawa M, Mizushima T, Sasakawa C.A bacterial effector targets the TRAF6-NFκB pathway to modulate the acute inflammatory response to bacterial invasion of epithelial cells.Virulence. 2012 Oct 1;3(6):518-21
  1. Sherman PM1, Cabana M, Gibson GR, Koletzko BV, Neu J, Veereman-Wauters G, Ziegler EE, Walker WA. Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27-28, 2008. J Pediatr. 2009 Nov;155(5): S61-70. doi: 10.1016/j.jpeds.2009.08.022.
  1. Parnell JA1, Reimer RA,Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults, Am J Clin Nutr. 2009 Jun;89(6):1751-9.
  1. Tursi A1, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, Forti G, Morini S, Hassan C, Pistoia MA, Modeo ME, Rodino’ S, D’Amico T, Sebkova L, Sacca’ N, Di Giulio E, Luzza F, Imeneo M, Larussa T, Di Rosa S, Annese V, Danese S, Gasbarrini A. Treatment of relapsing mild-tomoderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2010 Oct;105(10):2218-27.
  1. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn’s disease.Dig Dis Sci. 2000 Jul;45(7):1462-4.
  1. Velayudham A1, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology. 2009 Mar;49(3):989-997.
  1. Bercik P1, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, Verdu EF, Collins SM. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011 Aug;141(2):599-609, 609.e1-3. doi: 10.1053/j.gastro.2011.04.052. Epub 2011 Apr 30